Trials / Completed
CompletedNCT06053723
Bruxism and Severity of Temporomandibular Dsyfunction
The Effect of Bruxism on Masticatory Functionality and Severity of Temporomandibular Dsyfunction: A Cross-sectional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 91 (actual)
- Sponsor
- Bandırma Onyedi Eylül University · Academic / Other
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to investigate the effect of bruxism on Temporomanbular joint functionality and dysfunction severity in individuals with Temporomandibular Dysfunction (TMD).
Detailed description
The study included 91 individuals aged 20-55 years with TMD. Participants who volunteered to participate in the study signed the Informed Consent Form and completed the Descriptive Data Form including demographic characteristics. The presence of bruxism in individuals with TMD was questioned and the maximum mouth opening measurement was recorded. TMD severity was assessed by Fonseca's Anamnestic Questionnaire (FAQ), pain severity was assessed by Numeric Pain Scale (NPS), and masticatory and TMJ functioning was assessed by JAW Functional Limitation Scale-20 (JFLS-20). The evaluations of the participants were performed only once.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fonseca's Anamnestic Questionnaire | The questionnaire includes 10 questions about joint, head and neck pain, pain during masticatory activity, parafunctional habits, decreased joint motion, impaired occlusion and emotional stress. |
| OTHER | Numeric Pain Scale | It is a simple, reliable and short-term method that is frequently used to measure pain intensity in the clinic. |
| OTHER | Jaw Functionality Limitation Scale-20 | It includes a total of 20 items, with "0" indicating no limitation and "10" indicating severe limitation in each item, about the function of the TMJ during different activities, difficulty in chewing and jaw limitation. |
Timeline
- Start date
- 2023-04-15
- Primary completion
- 2023-09-01
- Completion
- 2023-09-15
- First posted
- 2023-09-26
- Last updated
- 2023-09-29
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06053723. Inclusion in this directory is not an endorsement.